← Leaderboards
Charles T Quinn
Ut Southwestern Medical Center
$1,161,856
Attributed
$2,479,817
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,479,817 · 4
By mechanism
U01$1,757,281 · 1
U54$722,536 · 3
Top collaborators
- Jay L Degen1 shared
- Punam Malik1 shared
- Jeffrey A Towbin1 shared
Others in their field
Top investigators on “Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Peter J. Snyder · University Of Pennsylvania$35,309,252
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$29,495,757
- Michael L. Terrin · Clinical Trials And Surveys Corporation$26,727,584
- Leonard I Zon · Children'S Hospital Boston$26,660,149
Research focus
AnemiaChronicSickle Cell AnemiaSickle CellResourcesAcuteRelative (Related Person)InvestigationAfrican AmericanAffectResolutionPainEventLaboratoriesPilot ProjectsSignal TransductionOther MinorityAcute PainConvalescenceAbsence Of Pain SensationControlled Clinical TrialsC-TelopeptideAdverse EventBone Turnover
Grant awards (7)
Cincinnati Center of Excellence in Hemoglobinopathies Research$1,757,281
U01 · FY2015 · HL
Acute Bone Turnover and Disordered Porphyrin Metabolism: Sickle Cell Pain$87,739
U54 · FY2009 · HL · contact PI
Acute Bone Turnover and Disordered Porphyrin Metabolism: Sickle Cell Pain$93,747
U54 · FY2008 · HL · contact PI
Dexamethasone for the Acute Chest Syndrome of Sickle Cell Anemia$202,213
U54 · FY2007 · HL · contact PI
Ketorolac Versus Ibuprofen for Painful Crisis of Sickle Cell Disease$60,208
U54 · FY2007 · HL · contact PI
Dexamethasone for Acute Chest Syndrome of Sickle Cell$180,000
U54 · FY2006 · HL · contact PI
Ketorolac Vs Ibuprofen for Painful Crisis of Sickle Cell$98,629
U54 · FY2006 · HL · contact PI